WSA
PRTA icon

Wall Street Associates’s Prothena Corp PRTA Stock Holding History

Wall Street Associates’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-15,411
Closed -$1.05M – 264
2015
Q4 		$1.05M Sell
15,411
-400
-3% -$24.1K 0.3% 119
2015
Q3 		$717K Buy
+15,811
New +$921K 0.14% 187

Other funds holding PRTA

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Wall Street Associates's PRTA Position: Q1 2016 in Review

Wall Street Associates sold out of Prothena Corp (PRTA) in Q1 2016, closing a stake of 15,411 shares — an estimated $1.05M sold.

Wall Street Associates first reported a position in PRTA in Q3 2015 and held it in 2 quarters. The position peaked at $1.05M in Q4 2015. 144 funds tracked by Wall St. Rank hold PRTA as of Q1 2016.

  • Wall Street Associates reported no remaining Prothena Corp position as of Q1 2016 after selling out during the quarter.
  • Wall Street Associates sold 15,411 Prothena Corp shares in Q1 2016, an estimated $1.05M.
  • Wall Street Associates first reported a position in Prothena Corp in Q3 2015 and held it in 2 quarters.
  • Wall Street Associates's Prothena Corp position peaked at $1.05M in Q4 2015.
  • 144 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2016.

Based on Wall Street Associates's 13F filing for Q1 2016, filed 13 May 2016.